CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria

NCT03477422 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infection Complicated
Acute Pyelonephritis

Interventions

DRUG: CSE-1034 (Ceftriaxone + Sulbactam + EDTA)
DRUG: Meropenem

Sponsor

Venus Remedies Limited